OPKO Health (OPK) Misses Q4 EPS by 9c, Revenue Beats
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.57 +5.37%
Revenue Growth %: -11.2%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: -11.2%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), $0.09 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $401.3 million versus the consensus estimate of $329.83 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
- UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
